IPRATROPIUM bromide, 20mcg/puff, 200 puffs, aerosol

STD DORAIPRA2SF

Valid Article

Former Code(s): DORAOCBZLB0018 DORAZNL0312 DORAIPRA2S-

Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03BB01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.

OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

https://unicat.msf.org/web/image/product.template/580277/image_1920?unique=ca8cca2

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

IPRATROPIUM aerosol

Therapeutic Action

Inhaled anticholinergic bronchodilator.

After inhalation, it causes rapid bronchodilation within minutes (approx. 3 min.) and lasting for 4-6 hours.

Indications

Control of symptoms related to bronchospasm in chronic obstructive pulmonary disease (COPD) in combination with inhaled salbutamol or salmeterol.

Acute management of severe asthma exacerbation in combination with inhaled salbutamol.

Instructions for use

Suspension or solution in a Pressurised Metered-Dose Inhaler (MDI): a small canister containing a mixture of medicine and pressurised propellant. The pressure from the propellant delivers the medication from the canister when the canister is pushed down into the boot/actuator.

Method of administration:

  • Shake the inhaler and ensure that liquid can be heard. Remove the mouthpiece cover.
  • Inhale fully, then exhale as completely as possible.
  • Place the lips firmly around the mouthpiece..
  • Start to inhale with a long, slow breath and continue breathing deeply while activating the inhaler (puff).
  • Remove the inhaler, close the lips, and hold the breath for 10 seconds or as long as comfortable.
  • Exhale, wait a few seconds, shake the inhaler again, and repeat for the next puff, if needed.

Manufacturers may express the content per puff as a "metered dose" (the quantity of the drug in the device metering chamber, excluding the valve) or as a "delivered dose" (the quantity of drug delivered to the user, excluding the mouthpiece). Always refer to the product leaflet.

The inhalers generally supplied by MSF are pressurised metered-dose inhalers (MDI). Refer to the information leaflet for appropriate instructions for use according to the inhaler model.

The pressurised metered-dose inhalers are CFC free. Chlorofluorocarbons (CFCs) are harmful to the ozone layer, and HFA (hydrofluoroalkane) propellants are a more effective, environmentally friendly alternative.

Image

Precautions for Use

Use in combination with inhaled salbutamol.

In children, use an inhalation chamber/spacer with or without mask (depending on the child's age) for each administration of a pressurised metered-dose inhaler.

In patients who have difficulty coordinating the actuation on the metered-dose inhaler and inhalation (e.g elderly patients), use an inhalation chamber/spacer to facilitate administration and improve the effectiveness of the product.

Do not use any mouthpiece other than the one supplied with the inhaler.

Transport Dangerous Goods

UN transport code:

  • UN 1950 - Aerosols, non-flammable (each not exceeding 1 L capacity)
  • Transport Class 2.2 - Non-flammable, non-toxic gases

Transport is only regulated for large quantities of aerosols.

Storage

  • Below 25ºC - Protect from sunlight
  • Used aerosols: do not pierce or incinerate. Empty any residual gas, then dispose of by burying.
Image